Biogen Inc Corporate Bonds and Leverage Analysis
| IDP Stock | EUR 152.00 0.25 0.16% |
Biogen Inc holds a debt-to-equity ratio of 0.717. . Biogen's financial risk is the risk to Biogen stockholders that is caused by an increase in debt.
Asset vs Debt
Equity vs Debt
Biogen's liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. Biogen's cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the Company is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps Biogen Stock's retail investors understand whether an upcoming fall or rise in the market will negatively affect Biogen's stakeholders.
For most companies, including Biogen, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for Biogen Inc, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, Biogen's management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
Biogen |
Given the importance of Biogen's capital structure, the first step in the capital decision process is for the management of Biogen to decide how much external capital it will need to raise to operate in a sustainable way. Once the amount of financing is determined, management needs to examine the financial markets to determine the terms in which the company can boost capital. This move is crucial to the process because the market environment may reduce the ability of Biogen Inc to issue bonds at a reasonable cost.
Biogen Inc Debt to Cash Allocation
Many companies such as Biogen, eventually find out that there is only so much market out there to be conquered, and adding the next product or service is only half as profitable per unit as their current endeavors. Eventually, the company will reach a point where cash flows are strong, and extra cash is available but not fully utilized. In this case, the company may start buying back its stock from the public or issue more dividends.
Biogen Inc has accumulated 6.28 B in total debt with debt to equity ratio (D/E) of 0.72, which is about average as compared to similar companies. Biogen Inc has a current ratio of 2.08, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Biogen until it has trouble settling it off, either with new capital or with free cash flow. So, Biogen's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Biogen Inc sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Biogen to invest in growth at high rates of return. When we think about Biogen's use of debt, we should always consider it together with cash and equity.Biogen Assets Financed by Debt
Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Biogen's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Biogen, which in turn will lower the firm's financial flexibility.Biogen Corporate Bonds Issued
Most Biogen bonds can be classified according to their maturity, which is the date when Biogen Inc has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Understaning Biogen Use of Financial Leverage
Biogen's financial leverage ratio helps determine the effect of debt on the overall profitability of the company. It measures Biogen's total debt position, including all outstanding debt obligations, and compares it with Biogen's equity. Financial leverage can amplify the potential profits to Biogen's owners, but it also increases the potential losses and risk of financial distress, including bankruptcy, if Biogen is unable to cover its debt costs.
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases worldwide. The company was founded in 1978 and is headquartered in Cambridge, Massachusetts. BIOGEN INC operates under Drug ManufacturersGeneral classification in Germany and is traded on Frankfurt Stock Exchange. It employs 9100 people. Please read more on our technical analysis page.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Biogen Stock
When determining whether Biogen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biogen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biogen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biogen Inc Stock:Check out the analysis of Biogen Fundamentals Over Time. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
What is Financial Leverage?
Financial leverage is the use of borrowed money (debt) to finance the purchase of assets with the expectation that the income or capital gain from the new asset will exceed the cost of borrowing. In most cases, the debt provider will limit how much risk it is ready to take and indicate a limit on the extent of the leverage it will allow. In the case of asset-backed lending, the financial provider uses the assets as collateral until the borrower repays the loan. In the case of a cash flow loan, the general creditworthiness of the company is used to back the loan. The concept of leverage is common in the business world. It is mostly used to boost the returns on equity capital of a company, especially when the business is unable to increase its operating efficiency and returns on total investment. Because earnings on borrowing are higher than the interest payable on debt, the company's total earnings will increase, ultimately boosting stockholders' profits.Leverage and Capital Costs
The debt to equity ratio plays a role in the working average cost of capital (WACC). The overall interest on debt represents the break-even point that must be obtained to profitability in a given venture. Thus, WACC is essentially the average interest an organization owes on the capital it has borrowed for leverage. Let's say equity represents 60% of borrowed capital, and debt is 40%. This results in a financial leverage calculation of 40/60, or 0.6667. The organization owes 10% on all equity and 5% on all debt. That means that the weighted average cost of capital is (.4)(5) + (.6)(10) - or 8%. For every $10,000 borrowed, this organization will owe $800 in interest. Profit must be higher than 8% on the project to offset the cost of interest and justify this leverage.Benefits of Financial Leverage
Leverage provides the following benefits for companies:- Leverage is an essential tool a company's management can use to make the best financing and investment decisions.
- It provides a variety of financing sources by which the firm can achieve its target earnings.
- Leverage is also an essential technique in investing as it helps companies set a threshold for the expansion of business operations. For example, it can be used to recommend restrictions on business expansion once the projected return on additional investment is lower than the cost of debt.